TenX Keane Acquisition Files 8-K

Ticker: CTOR · Form: 8-K · Filed: Jun 6, 2024 · CIK: 1851484

Sentiment: neutral

Topics: 8-K, disclosure, corporate-events

TL;DR

TenX Keane Acquisition filed an 8-K on 5/31, standard disclosure.

AI Summary

On May 31, 2024, TenX Keane Acquisition filed an 8-K report detailing other events. The company, incorporated in the Cayman Islands, is involved in the pharmaceutical preparations industry. Its principal executive offices are located at 420 Lexington Ave, Suite 2446, New York, NY 10170.

Why It Matters

This filing indicates ongoing corporate activities and disclosures for TenX Keane Acquisition, which is relevant for investors monitoring the company's compliance and operational status.

Risk Assessment

Risk Level: low — This is a routine 8-K filing for 'Other Events' and does not contain specific financial transactions or material changes that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing is for 'Other Events' and serves as a current report filed by TenX Keane Acquisition.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on May 31, 2024.

Where is TenX Keane Acquisition incorporated?

TenX Keane Acquisition is incorporated in the Cayman Islands.

What is the business address of TenX Keane Acquisition?

The business address is 420 Lexington Ave, Suite 2446, New York, NY 10170.

What is the Standard Industrial Classification (SIC) code for TenX Keane Acquisition?

The SIC code for TenX Keane Acquisition is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 589 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-06-06 17:28:32

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 31, 2024 TenX Keane Acquisition (Exact name of registrant as specified in its charter) Cayman Islands 001-41534 N/A (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 Lexington Ave , Suite 2446 New York , NY 10170 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (347) 627-0058 Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one ordinary share and one right TENKU The Nasdaq Stock Market LLC Ordinary shares, par value $0.0001 per share TENK The Nasdaq Stock Market LLC Rights, each right entitling the holder to receive two-tenths of one ordinary share TENKR The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 8.01. Other Events. In connection with the vote to approve the proposals at the extraordinary general meeting of shareholders of TenX Keane Acquisition (the "Company") held on January 17, 2024 (the "Meeting"), holders of 2,287,923 ordinary shares (the "Redeeming Shareholders") exercised their right to redeem their shares for cash at a redemption price of $10.90 per share, calculated based on the proxy record date of December 28, 2023, for an aggregate redemption amount of approximately $24.9 million. Consequently, this amount was removed from the Company's trust account to pay such holders. According to the Company's Second Amended and Restated Memorandum and Articles of Association and Definitive Proxy Statement, as supplemented, filed with the U.S. Securities and Exchange Commission on January 8, 2024, the redemption price should be calculated as of two business days prior to the Meeting, which date is January 12, 2024, with a redemption price of $11.02 per share. On May 31, 2024, the Company made additional payments to the Redeeming Shareholders of $268,645 in the aggregate. Such additional payments constitute top-up payments to cover the difference between the initially calculated redemption amount and the redemption amount based on the adjusted redemption price of $11.02 per share. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 6, 2024 TenX Keane Acquisition By: /s/ Xiaofeng Yuan Name: Xiaofeng Yuan Title: Chairman and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing